Completed NA INTERVENTIONAL 1-arm NCT05723822

Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments

A Pilot Study to Explore the Effects of Lower-Leg Mechanical Tactile Sensory Stimulation on the Gait Speed of Mildly Cognitively Impaired Individuals

Sponsor: Innovative Design Labs

Conditions Cognitive Decline Gait Disorders in Old Age Mild Cognitive Impairment

Interventions Walkasins

Updated 6 times since 2023 Last updated: May 9, 2023 Started: Feb 16, 2023 Primary completion: Mar 31, 2023 Completion: Mar 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05723822, this NA trial focuses on Cognitive Decline and Gait Disorders in Old Age and remains completed. Sponsored by Innovative Design Labs, it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Feb 2025 — Present [monthly]

Completed NA
Sep 2024 — Feb 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2023 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
May 2023 — Jul 2023 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 1 earlier version

Mar 2023 — May 2023 [monthly]

Recruiting NA

First recorded

Feb 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Innovative Design Labs
RxFunction Inc.

Data source: RxFunction Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States